tiprankstipranks
Trending News
More News >
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
US Market

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Statistics & Valuation Metrics

Compare
96 Followers

Total Valuation

Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $2.01M. The enterprise value is -$1.39M.
Market Cap$2.01M
Enterprise Value-$1.39M

Share Statistics

Shuttle Pharmaceuticals Holdings, Inc. has 10,984,291 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,984,291
Owned by Insiders
Owned by Institutions

Financial Efficiency

Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -12.90 and return on invested capital (ROIC) is -368.06%.
Return on Equity (ROE)-12.90
Return on Assets (ROA)-3.65K
Return on Invested Capital (ROIC)-368.06%
Return on Capital Employed (ROCE)5.03
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is >-0.01. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is 0.03.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio0.56
Price to Fair Value<0.01
Price to FCF-0.23
Price to Operating Cash Flow-0.21
PEG Ratio0.03

Income Statement

In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -9.14B in profits. Earnings per share was -3.19K.
Revenue0.00
Gross Profit0.00
Operating Income-7.70B
Pretax Income-9.14B
Net Income-9.14B
EBITDA-7.70B
Earnings Per Share (EPS)-3.19K

Cash Flow

In the last 12 months, operating cash flow was -8.62M and capital expenditures 0.00, giving a free cash flow of -8.62M billion.
Operating Cash Flow-8.62M
Free Cash Flow-8.62M
Free Cash Flow per Share-0.78

Dividends & Yields

Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.40
52-Week Price Change-94.63%
50-Day Moving Average0.27
200-Day Moving Average0.84
Relative Strength Index (RSI)38.93
Average Volume (3m)8.58M

Important Dates

Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is Sep 4, 2024, TBA Not Confirmed.
Last Earnings DateMay 14, 2024
Next Earnings DateSep 4, 2024
Ex-Dividend Date

Financial Position

Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 1.44, with Debt / Equity ratio of 33.61%
Current Ratio1.44
Quick Ratio1.44
Debt to Market Cap573.33
Net Debt to EBITDA<0.01
Interest Coverage Ratio-5.66K

Taxes

In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.23.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow-0.23
EV to Operating Cash Flow-0.23

Balance Sheet

Shuttle Pharmaceuticals Holdings, Inc. has $4.51M in cash and marketable securities with $1.10M in debt, giving a net cash position of -$3.41M billion.
Cash & Marketable Securities$4.51M
Total Debt$1.10M
Net Cash-$3.41M
Net Cash Per Share-$0.31
Tangible Book Value Per Share$0.25

Margins

Gross margin is -16.74%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-16.74%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast-7.18%

Scores

Smart ScoreN/A
AI Score32
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis